Effect of Tocilizumab in Reducing the Mortality Rate in COVID-19 Patients: A Systematic Review with Meta-Analysis

Data supporting the use of Tocilizumab (TCZ) in COVID-19 are contrasting and inconclusive. This meta-analysis aimed to assess TCZ effectiveness in reducing the mortality rate in COVID-19 patients. PubMed, Scopus, Embase, Cochrane, WILEY, and ClinicalTrials.gov were searched to evaluate observational...

Descripción completa

Detalles Bibliográficos
Autores principales: Conti, Valeria, Corbi, Graziamaria, Sellitto, Carmine, Sabbatino, Francesco, Maci, Chiara, Bertini, Nicola, De Bellis, Emanuela, Iuliano, Antonio, Davinelli, Sergio, Pagliano, Pasquale, Filippelli, Amelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307114/
https://www.ncbi.nlm.nih.gov/pubmed/34357095
http://dx.doi.org/10.3390/jpm11070628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307114/
https://www.ncbi.nlm.nih.gov/pubmed/34357095
http://dx.doi.org/10.3390/jpm11070628

Ejemplares similares